您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (2): 22-26.doi: 10.6040/j.issn.1671-7554.0.2021.1148

• 临床医学 • 上一篇    下一篇



  1. 山东大学生殖医学研究中心(山东大学附属生殖医院)生殖内分泌教育部重点实验室 山东省生殖医学重点实验室山东省生殖健康临床医学研究中心 国家辅助生殖与优生工程技术研究中心, 山东 济南 250012
  • 发布日期:2022-01-25
  • 通讯作者: 石玉华. E-mail:shiyuhua2003@126.com
  • 基金资助:

Expression of fatty acid transport protein 1 in granulosa cells of patients with polycystic ovary syndrome

SONG Tian, FU Linlin, WANG Qiumin, YANG Xiao, WANG Ying, BIAN Yuehong, SHI Yuhua   

  1. Center for Reproductive Medicine, Cheeloo College of Medicine, Shandong University;
    Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University;
    Shandong Key Laboratory of Reproductive Medicine;
    Shandong Provincial Clinical Research Center for Reproductive Health;
    National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Jinan 250012, Shandong, China
  • Published:2022-01-25

摘要: 目的 探讨脂肪酸转运蛋白1(FATP1)在多囊卵巢综合征(PCOS)患者颗粒细胞中的表达水平及临床意义。 方法 选取进行体外受精-胚胎移植(IVF-ET)的75例PCOS患者(PCOS组),根据体质量指数(BMI)≥25判定为肥胖的标准,分为PCOS正常体质量组(n=36)和PCOS肥胖组(n=39);同期62例因输卵管梗阻或男方因素助孕患者(对照组),分为对照正常体质量组(n=31)和对照肥胖组(n=31)。采用逆转录实时定量PCR(qRT-PCR)检测患者颗粒细胞中FATP1的表达,分析其在PCOS患者中的差异性表达。 结果 FATP1在PCOS组卵巢颗粒细胞中的表达高于对照组(P <0.001);FATP1在PCOS正常体质量组卵巢颗粒细胞中的表达高于对照正常体质量组(P<0.001); FATP1在PCOS肥胖组卵巢颗粒细胞中的表达高于对照肥胖组(P<0.001)。二分类Logistic回归分析结果显示,高FATP1表达水平(OR=4.242, 95%CI:2.025~8.883, P<0.001)、高抗苗勒氏管激素(AMH,OR=1.512, 95%CI:1.184~1.928, P<0.001)水平、 高黄体生成素/卵泡刺激素(LH/FSH,OR=4.301, 95%CI:1.265~15.304, P=0.02)比值和高睾酮(T,OR=1.059, 95%CI:1.003~1.117, P=0.038)水平是影响PCOS的危险因素。 结论 FATP1在PCOS患者颗粒细胞中表达增高,可能在PCOS发生发展中发挥重要作用。

关键词: 脂肪酸转运蛋白1, 多囊卵巢综合征, 颗粒细胞, 脂肪酸, 增殖

Abstract: Objective To investigate the expression of fatty acid transport protein 1(FATP1)in granulosa cells of patients with polycystic ovary syndrome(PCOS)and its clinical significance. Methods A total of 75 PCOS patients(PCOS group)undergoing in vitro fertilization-embryo transform(IVF-ET)were selected. According to the standard of body mass index(BMI)≥ 25 as obesity, the subjects were divided into normal BMI PCOS group(n=36)and obese PCOS group(n=39). Another 62 patients(control group)seeking assisted reproduction treatment due to tubal or male factors were divided into normal BMI control group(n=31)and obese control group(n=31). The expression of FATP1 in patients granulosa cells was detected with reverse transcription real-time quantitative PCR(qRT-PCR), and its differential expression in PCOS patients was analyzed. Results The expression of FATP1 was higher in PCOS group than in controls(P<0.001), higher in the normal BMI PCOS group than in normal BMI control group(P<0.001), and higher in obese PCOS group than in obese control group(P<0.001). Binary Logistic regression analysis showed that higher FATP1 level(OR=4.242, 95%CI: 2.025-8.883, P<0.001), higher anti-Mullerian hormone level(AMH, OR=1.512, 95%CI: 1.186-1.928, P<0.001), higher luteotropic hormone/follicle stimulating hormone ratio(LH/FSH, OR=4.401, 95%CI: 1.265-15.304, P=0.02), and higher testosterone level(T, OR=1.059, 95%CI: 1.003-1.117, P=0.038)were risk factors of PCOS. Conclusion The expression of FATP1 is increased in PCOS patients, suggesting that FATP1 may play an important role in the development of PCOS.

Key words: Fatty acid transport protein1, Polycystic ovary syndrome, Granulosa cells, Fatty acid, Proliferation


  • R711.75
[1] Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome [J]. Nat Rev Dis Primers, 2016, 2: 16057. doi: 10.1038/nrdp.2016.57.
[2] Stener-Victorin E, Deng Q. Epigenetic inheritance of polycystic ovary syndrome—challenges and opportunities for treatment [J]. Nat Rev Endocrinol, 2021, 17(9): 521-533.
[3] Wekker V, Dammen Lvan, Koning A, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis [J]. Hum Reprod Update, 2020, 26(6): 942-960.
[4] Li M, Zhao H, Zhao SG, et al. The HMGA2-IMP2 pathway promotes granulosa cell proliferation in polycystic ovary syndrome [J]. J Clin Endocrinol Metab, 2019, 104(4): 1049-1059.
[5] Mallick R, Basak S, Duttaroy AK. Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers [J]. Prog Lipid Res, 2021, 83: 101116. doi: 10.1016/j.plipres.2021.101116.
[6] Huang J, Zhu R, Shi D. The role of FATP1 in lipid accumulation: a review [J]. Mol Cell Biochem, 2021, 476(4): 1897-1903.
[7] Lopes-Coelho F, André S, Félix A, et al. Breast cancer metabolic cross-talk: fibroblasts are hubs and breast cancer cells are gatherers of lipids [J]. Mol Cell Endocrinol, 2018, 462(Pt B): 93-106.
[8] Zhang M, Di Martino JS, Bowman RL, et al. Adipocyte-derived lipids mediate melanoma progression via FATP proteins [J]. Cancer Discov, 2018, 8(8): 1006-1025.
[9] Cai M, Wang H, Li JJ, et al. The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise [J]. Brain Behav Immun, 2016, 57: 347-359. doi: 10.1016/j.bbi.2016.05.010.
[10] Cao Y, Chang S, Dong J, et al. Emodin ameliorates high-fat-diet induced insulin resistance in rats by reducing lipid accumulation in skeletal muscle [J]. Eur J Pharmacol, 2016, 780: 194-201. doi: 10.1016/j.ejphar.2016.03.049.
[11] Caballero B. Humans against obesity: who will win[J]. Adv Nutr, 2019, 10(suppl 1):S4-S9.
[12] 贺婷婷, 刘昕, 刘洪彬, 等. 多囊卵巢综合征患者颗粒细胞叉头框蛋白O1 mRNA的表达与意义[J]. 山东大学学报(医学版), 2019, 57(2): 75-79. HE Tingting, LIU Xin, LIU Hongbin, et al. Expression of Forkhead box protein O1 mRNA in granulosa cells of polycystic ovary sydrome patients and its significance [J]. Journal of Shandong University(Health Sciences), 2019, 57(2): 75-79.
[13] 贺婷婷, 刘红, 舒凯云, 等. 多囊卵巢综合征患者颗粒细胞中 microRNA-141的表达与意义[J]. 山东大学学报(医学版), 2019, 57(5):116-120. HE Tingting, LIU Hong, SHU Kaiyun, et al. Expression and significance of microRNA-141 in granulosa cells inpatients with polycystic ovary syndrome [J]. Journal of Shandong University(Health Sciences), 2019, 57(5): 116-120.
[14] Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment [J]. J Clin Endocrinol Metab, 2021,106(3): e1071-e1083.
[15] Leung KL, Sanchita S, Pham CT, et al. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome(PCOS)women during adipogenesis: evidence of cellular programming [J]. Clin Epigenetics, 2020,12(1): 181. doi: 10.1186/s13148-020-00970-x.
[16] Valckx SD, Arias-Alvarez M, De Pauw I, et al. Fatty acid composition of the follicular fluid of normal weight, overweight and obese women undergoing assisted reproductive treatment: a descriptive cross-sectional study [J]. Reprod Biol Endocrinol, 2014, 12: 13. doi: 10.1186/1477-7827-12-13.
[17] Maillard V, Desmarchais A, Durcin M, et al. Docosahexaenoic acid(DHA)effects on proliferation and steroidogenesis of bovine granulosa cells[J]. Reprod Biol Endocrinol, 2018, 16(1): 40. doi: 10.1186/s12958-018-0357-7.
[18] Zhou S, Xia L, Chen Y,et al. miR-3188 regulates proliferation and apoptosis of granulosa cells by targeting KCNA5 in the polycystic ovary syndrome[J]. Acta Biochim Pol, 2021, 68(1): 83-89.
[19] Bao D, Li M, Zhou D, et al. miR-130b-3p is high-expressed in polycystic ovarian syndrome and promotes granulosa cell proliferation by targeting SMAD4 [J]. J Steroid Biochem Mol Biol, 2021, 209: 105844. doi: 10.1016/j.jsbmb.2021.105844.
[20] Mendes C, Lopes-Coelho F, Ramos C, et al. Unraveling FATP1, regulated by ER-β, as a targeted breast cancer innovative therapy [J]. Sci Rep, 2019, 9(1): 14107. doi: 10.1038/s41598-019-50531-3.
[21] Xu XL, Deng SL, Lian ZX, et al. Estrogen receptors in polycystic ovary syndrome [J]. Cells, 2021,10(2): 459. doi: 10.3390/cells10020459.
[22] Lee EB, Chakravarthi VP, Wolfe MW, et al. ERβ regulation of gonadotropin responses during folliculogenesis [J]. Int J Mol Sci, 2021, 22(19):10348. doi: 10.3390/ijms221910348.
[23] Meroni M, Dongiovanni P, Longo M, et al. Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes [J]. EBioMedicine, 2020, 52: 102658. doi: 10.1016/j.ebiom.2020.102658.
[24] Ye G, Gao H, Wang Z, et al. PPARα and PPARγ activation attenuates total free fatty acid and triglyceride accumulation in macrophages via the inhibition of Fatp1 expression [J]. Cell Death Dis, 2019, 10(2): 39. doi: 10.1038/s41419-018-1135-3.
[25] Nishiyama K, Fujita T, Fujimoto Y, et al. Fatty acid transport protein 1 enhances the macrophage inflammatory response by coupling with ceramide and c-Jun N-terminal kinase signaling [J]. Int Immunopharmacol, 2018, 55: 205-215. doi: 10.1016/j.intimp.2017.12.003.
[26] Hipólito A, Martins F, Mendes C, et al. Molecular and metabolic reprogramming: pulling the strings toward tumor metastasis [J]. Front Oncol, 2021, 11: 656851. doi: 10.3389/fonc.2021.656851.
[1] 王晓磊 张海涛 张辉 郭成浩. 舒血宁注射液对高碘致培养血管内皮细胞损伤的保护作用[J]. 山东大学学报(医学版), 2209, 47(6): 38-.
[2] 赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58.
[3] 张振伟,李佳,陈克明. IGF2BP2/m6A/ITGA5信号轴调控肾透明细胞增殖和迁移[J]. 山东大学学报 (医学版), 2022, 60(9): 74-84.
[4] 虎娜,孙苗,邢莎莎,许丹霞,海小明,马玲,杨丽,勉昱琛,何瑞,陈冬梅,马会明. 月见草油抵抗多囊卵巢综合征大鼠卵巢氧化应激[J]. 山东大学学报 (医学版), 2022, 60(5): 22-30.
[5] 申晓畅,孙一卿,颜磊,赵兴波. 芳基烃受体核转位因子样蛋白2在子宫内膜癌中的表达[J]. 山东大学学报 (医学版), 2022, 60(5): 74-80.
[6] 亓梦雨,周敏然,孙洺山,李世洁,陈春燕. T大颗粒淋巴细胞白血病合并原发性骨髓纤维化1例[J]. 山东大学学报 (医学版), 2022, 60(2): 118-120.
[7] 李卉,姜朝阳,刘岩,张曼. 组蛋白去乙酰化酶SIRT1调控氧化低密度脂蛋白诱导巨噬细胞凋亡的表达[J]. 山东大学学报 (医学版), 2022, 60(1): 6-12.
[8] 王芳,陈华,商丽红,李茹月,李咏梅,杨玉娥,哈春芳. U0126对子宫内膜异位症大鼠MEK/ERK/NF-κB通路及增殖侵袭的影响[J]. 山东大学学报 (医学版), 2021, 59(9): 148-154.
[9] 牛群,石婧婧,符江. WNT5A基因对卵巢颗粒细胞胰岛素反应性和胰岛素抵抗的调控作用[J]. 山东大学学报 (医学版), 2021, 59(6): 57-63.
[10] 卢游,且迪,伍晋辉,杨凡. 干预Sonic Hedgehog信号通路对宫内发育迟缓新生大鼠学习记忆能力的影响[J]. 山东大学学报 (医学版), 2021, 59(5): 82-89.
[11] 韩笑,李雷,刘聪聪. 睾酮对于多囊卵巢综合征易感基因Tox3表达的影响[J]. 山东大学学报 (医学版), 2021, 59(4): 42-47.
[12] 宫小舒,吴日超,李秀芳,潘烨,王泽,石玉华. 603例多囊卵巢综合征患者不同促排卵内膜准备方案对冻胚移植结局的影响[J]. 山东大学学报 (医学版), 2021, 59(3): 48-54.
[13] 哈灵侠,殷婷,吴阳阳,黎维霞,杜玉冬. 多囊卵巢综合征患者中胰岛素抵抗与子宫内膜局部炎症因子及葡萄糖转运蛋白-4表达的相关性[J]. 山东大学学报 (医学版), 2021, 59(11): 41-47.
[14] 王正阳,夏艳,师凯旋,陶琨,王小杰. 曲美替尼在卵巢癌中对PAX8的表达作用[J]. 山东大学学报 (医学版), 2021, 59(10): 25-31.
[15] 杜甜甜,李娟,赵颖慧,段伟丽,王景,王允山,杜鲁涛,王传新. 长链非编码RNA LINC02474在结直肠癌中的表达特征及对细胞增殖的影响[J]. 山东大学学报 (医学版), 2021, 59(10): 59-69.
Full text



[1] 孙维彤,邹伟伟,李爱国,席延伟,张娜. 脂质体粒径对促进托氟啶口服吸收的影响[J]. 山东大学学报(医学版), 2007, 45(6): 639 -642 .
[2] 肖伟玲,林亚杰,牟东珍,孙萍,梁淑娟 . 分泌型人IL-1β表达载体的构建及在H7402细胞中的表达[J]. 山东大学学报(医学版), 2008, 46(2): 119 -122 .
[3] 于清梅,武玉玲,宋海岩,尹华伟,庄园 . p38丝裂原活化蛋白激酶在小鼠早期胚胎及围植入期子宫内膜的表达[J]. 山东大学学报(医学版), 2008, 46(2): 123 -127 .
[4] 张勇,叶静,郭新星,肖水清. 牙周膜牵张成骨快速移动牙牙髓中IL-8表达的变化[J]. 山东大学学报(医学版), 2008, 46(4): 379 -381 .
[5] 高静,陈雯,张同霞,王小花,戴廷军,姚红,赵秀鹤,迟兆富,单培彦 . 颞叶癫痫大鼠海马线粒体细胞色素氧化酶亚基Ⅲ和Ⅳ表达的变化[J]. 山东大学学报(医学版), 2007, 45(8): 817 -820 .
[6] 刘益民,杜鲁涛,王丽丽,蒋秀梅,李娟,曲爱林,王海燕,郑桂喜,张欣,杨咏梅,王传新. 膀胱癌患者血清microRNA检测中内参基因的筛选及验证[J]. 山东大学学报(医学版), 2014, 52(5): 86 -91 .
[7] 杨奎忠,孙雪飞,项继顺,杜庆聪,黄凤昌 . c-FLIP反义寡核苷酸对食管癌EC109细胞裸鼠移植瘤抑制作用的实验研究[J]. 山东大学学报(医学版), 2007, 45(12): 1234 -1238 .
[8] 俞新爽,韩俊庆,王兴文,盛巍,王瑜. 乳腺癌患者细胞免疫水平与预后危险因素的关系及临床意义[J]. 山东大学学报(医学版), 2007, 45(9): 934 -937 .
[9] 李安源,解砚英,李杰,王芃,徐淑兰,赵林 . 一服清颗粒治疗上呼吸道感染的药效学研究[J]. 山东大学学报(医学版), 2007, 45(9): 951 -954 .
[10] 王海峰,史本康,张克勤,李永智,朱耀丰,王海新. B超检测的精索静脉直径及返流与术后精液质量的关系[J]. 山东大学学报(医学版), 2007, 45(7): 751 -752 .